At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 27, 2026 at 16:01 ET
Analysis based on filing metadata only, document content was unavailable. Vor Biopharma filed a DEFA14A (additional definitive proxy soliciting materials) on April 27, 2026. Without readable content, the specific proposals or solicitation details cannot be assessed.
- Form DEFA14A filed by Vor Biopharma Inc. (VOR) on April 27, 2026
- Filing relates to proxy solicitation materials under Rule 14a-12
- Document content is not readable (binary/encoded)
- Market cap ~$675M; recent insider selling of $41.6M over 30 days
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access